Biotechnology Reagents & Kits Market Size, Share and Trends 2025 to 2034

Revenue, 2024

USD 517.48 Bn

Forecast Year, 2034

USD 1,454.92 Bn

CAGR, 2025 - 2034

10.89%

Report Coverage

Global

What is Biotechnology Reagents & Kits Market Size?

The global biotechnology reagents & kits market size accounted for USD 574.41 billion in 2025 and is expected to exceed around USD 1,454.92 billion by 2034, growing at a CAGR of 10.89% from 2025 to 2034.

Market Highlights

• North America held market share of 40.14% in 2024.
• By technology, the culture segment is expected to capture the biggest revenue share of 25% in 2024.
• By kits type, the analgesics segment is expected to acquire the largest share of 23% in 2024.
• By micro-organisms, the virus segment registered a maximum market share of 30% in 2024.
• By end use, the hospital-grade segment generated over 52% of revenue share in 2024.
• By tested parameters, the RNA segment is estimated to hold the highest market share of 30% in 2024.

Biotechnology Reagents & Kits Market Growth Factors

The global biotechnology reagents & kits market is primarily driven by the rapid developments in the biotechnology industry, increasing investments in the research & development by the biotechnology companies, increasing demand for the technological advancements in the biotechnology field, and growing biomolecular applications. High investments in the molecular biology has increased the consumption of the biotechnology reagents and kits in the recent years. The recent outbreak of the COVID-19 pandemic had a significant and positive impact on the market. COVID-19 had resulted in the increased usage of the RT PCR assay, as it is widely used for detecting the viral RNAs in the patients. Moreover, isolation of nucleic acids is an essential part of the COVID testing workflow. The lockdown situation resulted in the shortage of the purification kits and nucleic acid isolation. Several biotechnology companies started expanding its production capabilities, engaged in new product launches, and enhanced their distribution systems in order to tackle the shortage in supply and strengthen their positions in the market. Furthermore, the developments in the field of genome engineering, big data analytics, and gene therapy has positively contributed to the market growth in the past few years.

Market Outlook

• Industry Growth Overview:
  The biotechnology reagents & kits market is growing, driven by the rising R&D investment, a growing focus on targeted medicine, and advances in molecular biology such as PCR and next-generation sequencing.
• Global Expansion:
  The biotechnology reagents & kits market is experiencing global expansion, as the demand for modern diagnostics is helped by regulatory funding for life sciences research. North America is dominant in the market due to growing spending and a growing biotech sector.
• Major investors:
  The major investors in the biotechnology reagents and kits industry are significantly large, established life science and healthcare corporations that spend heavily in research and development (R&D), strategic acquisitions, and product novelty.

MarketScope

Segment Insights

Technology Insights

Based on technology, the cell culture segment accounted for around 25% of the market share in 2024 and is estimated to sustain its dominance during the forecast period. This can be attributed to the increased demand for the cell culture reagents among the researchers. The rapidly growing research activities owing to the increasing investments in the R&D is supplementing the market growth. The cell culture segment was closely followed by the PCR segment. PCR is one of the most important technologies used for analyzing and detecting particular gene sequence. The RT PCR has gained rapid traction owing to its accuracy, time-saving, and higher sensitivity characteristics, which made it very popular for the COVID-19 testing.

On the other hand, the sequencing segment is estimated to be the fastest-growing segment during the forecast period. It is considered to be the most reliable technology for cell lines categorization and is extensively used in the production of vaccines, gene therapies, and proteins. The rising advancements in the sequencing field is expected to drive the market growth in the forthcoming years.

Kits Type Insights

Based on kits type, the detection kits segment accounted for around 23% of the market share in 2024and is estimated to sustain its dominance during the forecast period. This is attributable to the extensive consumption of detection kits in the various end use sectors like healthcare, food, agriculture, and industrial processing. The demand for the detection kits surged in 2020, owing to the need for the COVID-19 testing across the globe. The production of the detection kits rapidly increased in the healthcare sectors owing the rising demand for the detections kits for detecting COVID-19 nucleic acid.

Micro-Organisms Insights

Based on micro-organisms, the virus segment accounted for over 30% of the market share in 2024 and is estimated to sustain its dominance during the forecast period. The growing applications of the viruses in the development of vaccines and gene therapies has boosted its demand and resulted in the dominance of this segment. The rising investments and research activities in the development of gene therapies and vaccines is expected to further fuel the growth of this segment.

On the other hand, the bacteria is estimated to be the most opportunistic segment owing to the growing usage of bacteria in cancer treatment. Bacteria can be potentially used as an anti-cancer agents. Therefore, the rising prevalence of cancer among the global population is expected to drive the growth of this segment. According to the International Agency for Research on Cancer, around 19.3 million new cancer cases and around 10 million cancer related deaths were reported in the year 2020, across the globe.

Tested Parameters Insights

Based on tested parameters, the RNA segment accounted for around 30% of the market share in 2024 and is estimated to sustain its dominance during the forecast period. In the past few years, the investments and the activities related to the extracellular RNA has gained rapid surge for the clinical diagnosis. The various research organizations and universities are increasingly engaged into the development of RNA based therapeutics, which is expected to further drive the growth of this segment in the foreseeable future.

On the other hand, the DNA segment is anticipated to grow at a rapid pace during the forecast period. This can be attributed to the growing applications of DNA in the pharmacogenomics, drug metabolism, forensics, and genetic screening. The demand for the DNA diagnostics is growing rapidly, which is expected to drive the growth of this segment.

End Use Insights

Based on end use, the healthcare segment accounted for around 52% of the market share in 2024 and is estimated to sustain its dominance during the forecast period. This can be simply attributed to the increased demand for the biotechnology reagents and kits in the numerous research organizations for the clinical trials and diagnostics. Further, the rising popularity of the personalized medicines among the population is further fueling the segment growth.

On the other hand, the food & agriculture segment is estimated to be the most opportunistic segment during the forecast period. This is attributed to the increased activities in the biotechnology sectors towards the development of various recombinant DNA technology and plant tissue culture technology for improving the yield in the agricultural sectors.

Regional Insights

U.S. Biotechnology Reagents & Kits Market Size and Growth 2025 to 2034

The U.S. pharmaceutical intermediates market size is evaluated at USD 163.43 billion in 2025 and is projected to be worth around USD 433.55 billion by 2034, growing at a CAGR of 11.46% from 2025 to 2034.

U.S.: Significant research funding

The U.S. government, through agencies such as the National Institutes of Health (NIH), offers substantial funding for life sciences research, including genomics and molecular diagnostics. This consistent economic support drives basic and applied research, increasing innovation and demand for high-quality reagents and kits, which drives the growth of the market.

North America: Presence of major key players

Based on region, North America accounted for around 40.14% of the market share in 2024 and is estimated to sustain its dominance during the forecast period. The presence of several key market players in the regions and their increased investments in the biotechnology and increased number of developmental strategies undertaken by them, significantly influences the market growth in the region. The rapidly growing biotechnology industry in the US and increased activities in the life sciences field is propelling the market growth in the region.

Asia Pacific: Increasing government support

The Asia Pacific is expected to witness remarkable CAGR during the forecast period. The rising prevalence of chronic diseases among the population, increased government initiatives to develop the healthcare infrastructure, and growing demand for the advanced therapeutics are the various factors that propels the growth of the biotechnology reagents & kits market in the Asia Pacific region.

India: Strong pharmaceutical industry

India imports a significant majority it estimated at 70-80% of its high-technology healthcare devices and components for modern kits, though domestic manufacturing is increasing rapidly in the consumables section. The increasing prevalence of long-term and infectious diseases necessitates a continuous and high demand for efficient diagnostic services, which drives the growth of the market.

Europe: Stringent Regulatory Frameworks

Europe is experiencing substantial growth in the market due to European nations having vigorous and well-established medical care systems and diagnostic laboratory systems. This infrastructure drives the high volume of routine and particular diagnostic testing, confirming a consistent demand for reagents and kits. Both governments and private pharmaceutical and biotechnology companies dedicate substantial resources to research and development, which contributes to the growth of the market.

U.K.: Industry Collaboration and R&D

The UK is a hub for leading universities like the University of Oxford, the University of Cambridge, and Imperial College London, which are the main centers for life sciences research and significant consumers and innovators of advanced reagents and kits. The UK government has made considerable commitments to progressing the life sciences sector. A strong network of both large pharmaceutical companies and innovative small to medium-sized biotech organizations.

Value Chain Analysis – Drive by Wire Market

• R&D: The R&D process in the reagents and kits industry involves many systematic steps, from initial idea generation to commercialization and post-market surveillance.
  Key Players: F. Hoffmann-La Roche Ltd.
• Clinical Trials: Clinical trials for reagents and kits involve a different process than outdated drug trials, focusing on safety and performance authentication in a relevant healthcare setting
  Key Players: Merck KGaA
• Patient Services: It significantly involves processes that help the efficient utilization of diagnostic products in the wider healthcare system, eventually influencing patient results.
  Key Players: Thermo Fisher Scientific Inc.

Top Vendors in the Biotechnology Reagents & Kits Market & Their Offerings

Segments Covered in the Report

By Technology

• PCR
• Cell Culture
• LAMP
• Chromatography
• Sequencing
• Flow Cytometry
• Electrophoresis
• Others

By Kits Type

• Amplifications Kits
• Isolation Kits
• Purification Kits
• Detection Kits
• Others

By Micro-Organisms

• Virus
• Bacteria
• Fungi
• Parasites

By Tested Parameters

• RNA
• DNA
• Enzymes
• Proteins
• Others

By End User

• Healthcare
• Food & Agriculture
• Industrial Processing
• Natural Resource & Environment
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa